Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), today announced positive results from its Phase 2 study of oral, once-daily VTX3232 in patients with Obesity and Cardiovascular Risk ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences ...

Scientists have long sought measurable signs in the body, called biomarkers, that reliably reveal our biological age or ...

New Mexico State University’s assistant professor Matthew Guberman-Pfeffer has been recognized as 2025 Trailblazer by ...

Expedition Medicines has emerged from stealth with $50 million in funding from Flagship Pioneering. The start-up uses ...

Tennessee Tech is turning waste into opportunity with the launch of a new campus composting project that brings together ...

FMC-376 demonstrated robust anti-tumor activity across preclinical models and led to deeper inhibition of KRAS downstream ...

About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...

Crain's exclusive ranking reveals the Chicago-area companies coming up with the most ingenious inventions and clever new ways ...

Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...